Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancerCentral MessagePerspective

Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancerCentral MessagePerspective

Objectives: T3 disease comprises heterogeneous morphologic characteristics, a variation only further complicated when in the context of N2-confirmed involvement. This study aims to examine whether or not specific features of T3 N2 non–small cell lung cancer are associated with improved 5-year overal...

Full description

Bibliographic Details
Main Authors: Jennifer C. Wang, BS, Li Ding, MD, MPH, Elizabeth A. David, MD, MAS, Scott M. Atay, MD, Sean C. Wightman, MD, P. Michael McFadden, MD, Takashi Harano, MD, Anthony W. Kim, MD
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:JTCVS Open
Subjects:
non–small cell lung cancer
guideline concordant therapy
multimodal therapy
surgery
adjuvant therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273622000432

Internet

http://www.sciencedirect.com/science/article/pii/S2666273622000432

Similar Items